AUSTIN, Texas--(BUSINESS WIRE)--ArthroCare® Corp. (Nasdaq:ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, announced that for the third quarter ended September 30, 2006 total revenues grew 21 percent to $64.7 million. Product revenue growth of 20 percent was led by a 21 percent increase in our Sports Medicine business unit and continued strong growth in ENT revenues. On an as-reported basis, ArthroCare’s net income grew to $8.7 million, or $0.31 per diluted share, for the third quarter of 2006, reflecting growth in the Company’s three major business units coupled with effective cost control.
